The Mississippi Senate Public Health Committee approved a bill that would allow clinical trials of Ibogaine, a psychoactive substance, for treating opioid addiction and neurological conditions. The legislation, HB 314, is sponsored by Rep. Samuel Creekmore (R), and aims to facilitate FDA-regulated research in the state.
Senator Josh Harkins (R) explained that Ibogaine is found in the root bark of the African Aboga plant and interacts with multiple brain systems. Harkins cited studies from ...
This press release highlights the growing pressure on the iboga plant due to increasing demand for ibogaine, used in addiction treatment.
As research into ibogaine's therapeutic benefits progresses, the pressure on the wild iboga population has intensified. The iboga tree faces a growing …
HB 2817 and HB 2961 would provide money for ibogaine research. Ibogaine is a psychoactive compound derived from the root bark of the iboga plant.
Missouri lawmakers have approved legislation aimed at expanding therapeutic access to and research on psychedelics such as psilocybin and ibogaine for adults and military veterans.
On Wednesday, members of the House Emerging Issues Committee passed two psychedelics proposals—combining two psilocybin- and two ibogaine-focused bills from Reps. Matthew Overcast (R) and Rep. Richard West (R)—that would take a series of steps to fund psychedelics studies, prepare for federal approval of novel therapeutics and create ...